Show document

A+ | A- | | SLO | ENG

Title: Biospecifična protitelesa za zdravljenje limfomov : mosunetzumab, glofitamab, epkoritmab, odronekstamab in plamotamab Authors: ID Miljković, Milica (Author) Files: PDF - Presentation file, download (784,92 KB) MD5: 12AEE9EF6D11CD779976EC9BDDF272CA   Language: Slovenian Typology: 1.09 - Published Professional Conference Contribution Organization: OI - Institute of Oncology Keywords: internistična onkologija, biospecifična protitelesa, kemoterapija Publication status: Published Publication version: Version of Record Place of publishing: Ljubljana Publisher: Sekcija za internistično onkologijo SZD : Onkološki inštitut Year of publishing: 2024 Number of pages: Str. 89-94 Source: Ljubljana PID: 20.500.12556/DiRROS-18755  UDC: 616-006 COBISS.SI-ID: 188722947  Copyright: by Authors Publication date in DiRROS: 19.04.2024 Views: 224 Downloads: 65 Metadata:     Cite this work Plain text BibTeX EndNote XML EndNote/Refer RIS ABNT ACM Ref AMA APA Chicago 17th Author-Date Harvard IEEE ISO 690 MLA Vancouver : Copy citation

Share: Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a monograph

Title:	Dnevi internistične onkologije 2024 : inovativna zdravila v onkologiji
Editors:	Erika Matos, Cvetka Grašič-Kuhar, Tanja Ovčariček, Zvezdana Vukmirović, Amela Duratović Konjević
Place of publishing:	Ljubljana
Publisher:	Sekcija za internistično onkologijo SZD
Year of publishing:	2024
ISBN:	978-961-7092-58-5
COBISS.SI-ID:	186202627

Back